Inhibition of GSK3β activity by treatment with each drug and the CLOVA cocktail was confirmed by the decreased level of pGSS641 in tumor cells, especially in satellite lesions, and the effect of CLOVA cocktail was strongest (Figure 3A, Supplementary Figure 4). The gene discussed is GSK3B; the disease is neoplasm.